The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy
Open accessAbstract
BACKGROUND & AIMS: Patients with cirrhosis and variceal hemorrhage have a high risk of rebleeding. We performed a prospective randomized trial to compare the prevention of rebleeding in patients given a small-diameter covered stent vs those given hepatic venous pressure gradient (HVPG)-based medical therapy prophylaxis. METHODS: We performed an open-label study of patients with cirrhosis (92% Child class A or B, 70% alcoholic) treated at 10 medical centers in Germany. Patients were assigned randomly more than 5 days after variceal hemorrhage to groups given a small covered transjugular intrahepatic portosystemic stent-shunt (TIPS) (8 mm; n = 90), or medical reduction of portal pressure (propranolol and isosorbide-5-mononitrate; n = 95). HVPG was determined at the time patients were assigned to groups (baseline) and 2 weeks later. In the medical group, patients with an adequate reduction in HVPG (responders) remained on the drugs whereas nonresponders underwent only variceal band ligation. The study was closed 10 months after the last patient was assigned to a group. The primary end point was variceal rebleeding. Survival, safety (adverse events), and quality of life (based on the Short Form-36 health survey) were secondary outcome measures. RESULTS: A significantly smaller proportion of patients in the TIPS group had rebleeding within 2 years (7%) than in the medical group (26%) (P = .002). A slightly higher proportion of patients in the TIPS group experienced adverse events, including encephalopathy (18% vs 8% for medical treatment; P = .05). Rebleeding occurred in 6 of 23 patients (26%) receiving medical treatment before hemodynamic control was possible. Per-protocol analysis showed that rebleeding occurred in a smaller proportion of the 32 responders (18%) than in nonresponders who received variceal band ligation (31%) (P = .06). Fifteen patients from the medical group (16%) underwent TIPS placement during follow-up evaluation, mainly for refractory ascites. Survival time and quality of life did not differ between both randomized groups. CONCLUSIONS: Placement of a small-diameter, covered TIPS was straightforward and prevented variceal rebleeding in patients with Child A or B cirrhosis more effectively than drugs, which often required step-by-step therapy. However, TIPS did not increase survival time or quality of life and produced slightly more adverse events. Clinical Trial no: ISRCTN 16334693.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941 · cited 1×
“Five patients in group A received liver transplantation after a median of seven (6-66) months and four in group B after 11 (3-48) months with one perioperative death.”
Background(1994) · Medical Entomology and Zoology · Cited by 4,156
de Franchis, R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.004 · Cited by 2,281
Power and sample size calculations
Dupont, W. D., & Plummer, W. D. (1990) · Controlled Clinical Trials · doi:10.1016/0197-2456(90)90005-m · Cited by 2,092
Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding
García-Pagán, J. C., Caca, K., Bureau, C., Laleman, W., Appenrodt, B., Luca, A., Abraldes, J. G., Nevens, F., Vinel, J. P., Mössner, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0910102 · Cited by 1,244
Self-citationde Franchis, R. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.009 · Cited by 1,029
The course of patients after variceal hemorrhage
Graham, D. Y., & Smith, J. L. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90144-x · Cited by 996
The clinical use of HVPG measurements in chronic liver disease
Bosch, J., Abraldes, J. G., Berzigotti, A., & García-Pagan, J. C. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.149 · Cited by 727
Feu, F., García-Pagán, J. C., Bosch, J., Luca, A., Escorsell, A., Rodés, J., & Terés, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91740-3 · Cited by 591
Franchis, R. D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80320-7 · Cited by 587
Ware, J. E., Gandek, B., Kosinski, M., Aaronson, N. K., Apolone, G., Brazier, J., Bullinger, M., Kaasa, S., Leplège, A., Prieto, L., et al. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00108-5 · Cited by 560
Monescillo, A., Martínez-Lagares, F., Ruíz-del-Árbol, L., Sierra, A., Guevara, C., Jim�nez, E., Marrero, J. M., Buceta, E., Sánchen, J., Castellot, A., et al. (2004) · Hepatology · doi:10.1002/hep.1840400408 · Cited by 536
Sersté, T., Melot, C., Francoz, C., Durand, F., Rautou, P.-E., Valla, D., Moreau, R., & Lebrec, D. (2010) · Hepatology · doi:10.1002/hep.23775 · Cited by 530
The hepatic venous pressure gradient: Anything worth doing should be done right
Groszmann, R. J., & Wongcharatrawee, S. (2004) · Hepatology · doi:10.1002/hep.20062 · Cited by 524
D’Amico, G., Garcia-Pagan, J. C., Luca, A., & Bosch, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.013 · Cited by 512
Prevention of variceal rebleeding
Bosch, J., & García-Pagán, J. C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12778-x · Cited by 423
Reiberger, T., Ulbrich, G., Ferlitsch, A., Payer, B. A., Schwabl, P., Pinter, M., Heinisch, B. B., Trauner, M., Kramer, L., Peck-Radosavljevic, M., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304038 · Cited by 342
Vorobioff, J., Groszmann, R., Picabea, E., Gamen, M., Villavicencio, R., Bordato, J., Morel, I., Audano, M., Tanno, H., Lerner, E., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8780575 · Cited by 322
Bernard, B., Lebrec, D., Mathurin, P., Opolon, P., & Poynard, T. (1997) · Hepatology · doi:10.1002/hep.510250112 · Cited by 256
Escorsell, À., Bañares, R., García-Pagán, J. C., Gilabert, R., Moitinho, E., Piqueras, B., Bru, C., Echenagusia, A., Granados, A., & Bosch, J. (2002) · Hepatology · doi:10.1053/jhep.2002.30418 · Cited by 231
Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis†
Schepke, M., Kleber, G., Nürnberg, D., Willert, J., Koch, L., Veltzke-Schlieker, W., Hellerbrand, C., Kuth, J., Schanz, S., Kahl, S., et al. (2004) · Hepatology · doi:10.1002/hep.20284 · Cited by 226
Self-citationVillanueva, C., Aracil, C., Colomo, A., Hernández–Gea, V., López–Balaguer, J. M., Alvarez–Urturi, C., Torras, X., Balanzó, J., & Guarner, C. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.048 · Cited by 217
Meta-analysis: Combination Endoscopic and Drug Therapy to Prevent Variceal Rebleeding in Cirrhosis
Gonzalez, R., Zamora, J., Gomez-Camarero, J., Molinero, L.-M., Bañares, R., & Albillos, A. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-2-200807150-00007 · Cited by 207
Sinagra, E., Perricone, G., D'Amico, M., Tinè, F., & D’Amico, G. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12634 · Cited by 168
Riggio, O., Ridola, L., Angeloni, S., Cerini, F., Pasquale, C., Attili, A. F., Fanelli, F., Merli, M., & Salvatori, F. M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.033 · Cited by 147
New therapeutic paradigm for patients with cirrhosis
Tsochatzis, E. A., Bosch, J., & Burroughs, A. K. (2012) · Hepatology · doi:10.1002/hep.25915 · Cited by 145
Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review
Puente, Á., Hernández–Gea, V., Graupera, I., et al. (2013) · Liver International · doi:10.1111/liv.12452 · Cited by 133
Mura, V. L., Abraldeṣ, J. G., Raffa, S., Retto, O., Berzigotti, A., García‐Pagán, J. C., & Bosch, J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.015 · Cited by 132
Propranolol for the prevention of first esophageal variceal hemorrhage: A lifetime commitment?
Abraczinskas, D. R., Ookubo, R., Grace, N. D., Groszmann, R. J., Bosch, J., García–Tsao, G., Richardson, C. R., Matloff, D. S., Rodés, J., & Conn, H. O. (2001) · Hepatology · doi:10.1053/jhep.2001.29305 · Cited by 128
Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis
Khan, S. A., Smith, C. T., Williamson, P. R., & Sutton, R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000553.pub2 · Cited by 124
Jairath, V., Rehal, S., Logan, R. F., Kahan, B. C., Hearnshaw, S., Stanworth, S. J., Travis, S. P. L., Murphy, M. F., Palmer, K. R., & Burroughs, A. K. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.12.010 · Cited by 113
Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding
Patch, D., Armonis, A., Sabin, C. A., Christopoulou, K., Greenslade, L., McCormick, P. A., Dick, R., & Burroughs, A. K. (1999) · Gut · doi:10.1136/gut.44.2.264 · Cited by 98
Li, L., Yu, C., & Li, Y. (2011) · Canadian Journal of Gastroenterology · doi:10.1155/2011/346705 · Cited by 72
Gluud, L. L., Langholz, E., & Krag, A. A. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04418.x · Cited by 70
Cited by
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
Angeli, P., Bernardi, M., Villanueva, C., Francoz, C., Mookerjee, R. P., Trebicka, J., Krag, A., Laleman, W., & Gines, P. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.024 · Cited by 2,905
Self-citationGarcia‐Tsao, G., Abraldes, J. G., Berzigotti, A., & Bosch, J. (2017) · Hepatology · doi:10.1002/hep.28906 · Cited by 2,154
Kaplan, D. E., Ripoll, C., Thiele, M., Fortune, B. E., Simonetto, D. A., Garcia-Tsao, G., & Bosch, J. (2024) · Hepatology · doi:10.1097/hep.0000000000000647 · Cited by 486
Abraldes, J. G., Villanueva, C., Aracil, C., Turnes, J., Hernandez-Guerra, M., Genesca, J., Rodriguez, M., Castellote, J., García-Pagán, J. C., Torres, F., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.004 · Cited by 339
Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
Tripathi, D., Stanley, A. J., Hayes, P. C., Travis, S., Armstrong, M. J., Tsochatzis, E. A., Rowe, I. A., Roslund, N., Ireland, H., Lomax, M., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320221 · Cited by 314
Metadata
- Authors
- Sauerbruch, T., Mengel, M., Dollinger, M., Zipprich, A., Rössle, M., Panther, E., Wiest, R., Caca, K., Hoffmeister, A., Lutz, H., Schoo, R., Lorenzen, H., Trebicka, J., Appenrodt, B., Schepke, M., & Fimmers, R.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 149
- Issue
- 3
- Pages
- 660-668.e1
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1507700591
- Cited by
- 261
- References
- 34
- FWCI
- 12.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.